Yanhong. Guo, et.al., Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production., The Journal of clinical investigation, 2015, 125
Yanhong. Guo, et.al., Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production., The Journal of clinical investigation, 2015, 125